Related Experiment Video
Updated: Jul 7, 2025

07:56
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
4.3K
Particle filter-based parameter estimation algorithm for prognostic risk assessment of progression in non-small cell
Shi Shang1, Junyi Yuan1, Changqing Pan2
1Information Center, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
BMC Medical Informatics and Decision Making
|December 21, 2023
Summary
This study introduces an improved model for assessing non-small cell lung cancer (NSCLC) survival risk using particle filtering. The new method enhances prediction accuracy by effectively incorporating data from new patients, aiding precision medicine.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning
Background:
- Non-small cell lung cancer (NSCLC) poses a significant health threat, with electronic medical records offering potential for risk assessment and recurrence reduction.
- Traditional machine learning models face challenges in improving prediction accuracy and utilizing new patient data effectively as sample sizes grow.
Purpose of the Study:
- To develop a dynamic NSCLC postoperative survival risk assessment model that continuously updates parameters using new patient data.
- To enhance model accuracy and effectively integrate characteristic data from subsequent patients for improved risk prediction.
Main Methods:
- A novel approach combining particle filtering and parameter estimation was employed to build the NSCLC survival risk model.
- Empirical analysis experiments were conducted to demonstrate the feasibility and evaluate the performance of the proposed method.
Main Results:
- The developed model achieved an overall accuracy of 92% and a recall of 71% for deceased patients.
- Compared to traditional machine learning models, the particle filter-based approach improved accuracy by 2% and recall for deceased patients by 11%.
Conclusions:
- The particle filter-based model effectively utilizes subsequent patient data, offering greater relevance for individual patient risk assessment.
- This method supports precision medicine by providing a more accurate and adaptive approach to NSCLC survival risk prediction.
Related Concept Videos
Kaplan-Meier Approach
149
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
149
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355

